Product Information
GABAPENTIN 100 MG CAPSULE is a generic product labeled by Rising Pharma Holdings Inc., priced at $0.0218 per EA under NDC 16571086710. Its NADAC has been published 71 times since May 28, 2025.
FDA first approved this application on Mar 24, 2017. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
100 mg/1
Manufacturer
Rising Pharma Holdings Inc.NDC
16571086710
Classification
Generic
Dosage Form
CAPSULE
Route
ORAL
Effective Date
9/23/2026
Active Ingredients
GABAPENTINApproval Type
Generic (ANDA)
FDA Application
ANDA207099FDA Approved
3/24/2017
TE Code
AB
On Market Since
8/1/2022
Pharmacological Classes
Price Statistics
The NADAC for GABAPENTIN 100 MG CAPSULE has been published 71 times since May 28, 2025, and over the history we have for it it has declined 3.0%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.0218 per EA |
|---|---|
| All-time high | $0.0225 (Jun 11, 2025) |
| All-time low | $0.0208 (Jul 22, 2026) |
| 52-week high | $0.0218 |
| 52-week low | $0.0208 |
| Median price | $0.0212 |
| Average price | $0.0214 |
| Largest weekly change | +4.2% (Sep 23, 2026) |
| Weeks tracked | 71 |
| Tracking since | May 28, 2025 |
Generic Alternatives
The matcher finds 8 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 4% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Rising Pharma Holdings Inc. manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
gabapentin market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of GABAPENTIN 100 MG CAPSULE?
The current National Average Drug Acquisition Cost (NADAC) for GABAPENTIN 100 MG CAPSULE, manufactured by Rising Pharma Holdings Inc., is $0.0218 per EA (NDC 16571086710), effective Sep 30, 2026.
How has the price of GABAPENTIN 100 MG CAPSULE changed over time?
Over the history we have for it, the NADAC for GABAPENTIN 100 MG CAPSULE has declined 3.0%. It has been tracked across 71 weekly CMS publications since May 28, 2025.
What are the highest and lowest recorded NADAC prices for GABAPENTIN 100 MG CAPSULE?
Since May 28, 2025, the NADAC for GABAPENTIN 100 MG CAPSULE has ranged from a low of $0.0208 (Jul 22, 2026) to a high of $0.0225 (Jun 11, 2025), with a median of $0.0212 per EA.
Are there cheaper alternatives to GABAPENTIN 100 MG CAPSULE?
Yes. 8 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, GABAPENTIN 100 MG CAPSULE, is $0.0209 per EA — about 4% below GABAPENTIN 100 MG CAPSULE.
Who manufactures GABAPENTIN 100 MG CAPSULE?
GABAPENTIN 100 MG CAPSULE (NDC 16571086710) is labeled by Rising Pharma Holdings Inc., and CMS classifies it as a generic product.